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II. Synthesis and Characterization of FITC-LPRT-
Fmoc-LPRT-OH (S2)
dissolved in NMP to a final volume of 7.00 mL. This solution was mixed until all reagents had dissolved, and then added to the deprotected resin. Couplings were incubated for 12-24 h at RT. The resin was then washed with ~30 mL of NMP (3x, 3-5 min per wash). The extent of coupling was assessed by Kaiser test. In the event that the coupling was incomplete, the above procedure was repeated. Fmoc removal was then achieved by exposing the resin to 20 mL of 80:20 NMP/piperidine for 20 min at RT, followed by additional washing with ~30 mL of NMP (3x, 3-5 min per wash). Repeated cycles of amino acid coupling and Fmoc deprotection were then repeated to complete the synthesis of resin-bound intermediate S1. Resin S1 was cleaved by treatment with ~5 mL of 95:3:2 TFA/TIPS/H 2 O (5x, ~30 min each) and the combined cleavage solutions were concentrated. Crude S2 was precipitated from cold diethyl ether and dried (184 mg, 87% yield based on estimated resin loading). 
FITC-LPRT-OMe (1).
Intermediate S4 (7.0 mg, 11 µmol) was combined with FITC isomer I (4.9 mg, 13 µmol), and DIPEA (15 µL, 86 µmol) in 120 µL of NMP. The reaction was incubated at room temperature for 2 h. Crude 1 was then precipitated from cold diethyl ether and the resulting solid 
Fmoc-LPRT-OMe (S5
III. Protein Cloning and Expression
SrtA strep . The expression plasmid for SrtA strep (residues 82-249) including an N-terminal His 6 tag has been described. 3 The construct was transformed into E. coli BL-21. Cells were grown in 2 L of sterile LB containing kanamycin (30 µg/mL) to an optical density of ~0.7 at 600 nm. Cells were induced with containing SrtA strep were pooled and subjected to a second round of Ni-affinity chromatography.
Purified SrtA strep was then dialyzed against 50 mM Tris pH 8.0, 150 mM NaCl, and 10% glycerol. G 5 -eGFP and dual labeling eGFP substrate. G 5 -eGFP (containing a C-terminal His 6 tag) and the eGFP dual labeling substrate (containing an N-terminal thrombin cleavage site and a C-terminal LPETG S10 motif followed by a His 6 tag) and were prepared in pET28a+ (Novagen) using a Quickchange® II SiteDirected Mutagenesis Kit (Stratagene). The template plasmid used for mutagenesis has been described. UCHL3 and dual labeling UCHL3 substrate. UCHL3 containing a single N-terminal glycine residue was produced in E. coli as described previously. 8 This construct (in pET28a+, Novagen) was then used to prepare the dual labeling UCHL3 substrate. Synthetic 5′-phosphorylated oligonucleotide duplexes containing appropriate sticky ends were designed to achieve insertion of an N-terminal thrombin site and a C-terminal LPETG sequence separated from UCHL3 by a GGGGSGGGGS spacer in two sequential cloning steps. Duplexes were annealed before ligation into the parent vector. The C-terminal insertion was performed first using the PstI and XhoI restriction sites. The result of using the XhoI site was the addition of a His 6 -tag after the LPETG sequence. The N-terminal insertion was then achieved using the XbaI and NdeI restriction sites. This plasmid was then transformed into E. coli BL21. Cells were grown in sterile LB containing kanamycin (30 µg/mL) to an optical density of ~0.6-0.9 at 600 nm. 
Dual labeling of eGFP
Immediately prior to starting the dual labeling sequence, the eGFP stock was thawed and again purified by affinity chromatography over commercial Ni-NTA resin. After binding eGFP to the resin, the column was washed with 20 mM Tris pH 8.0, 150 mM NaCl, and 20 mM imidazole. The protein was eluted with 20 mM Tris pH 8.0, 150 mM NaCl, and 300 mM imidazole. This material was buffer exchanged into 20 mM Tris pH 8.0, 150 mM NaCl using a NAP TM 5 Sephadex TM column (GE Healthcare) and concentrated. The concentration was estimated to be 84 µM by UV-vis spectroscopy using eGFP absorbance at 488 nm (extinction coefficient 55,900 M -1 cm -1 ). Coomassie stained gels were imaged using a CanoScan 8600F scanner. Protein purity was estimated from these images using ImageJ 1.42q densitometry software. 
Dual labeling of UCHL3
